Research programme: inflammatory bowel diseases therapeutic- Applied Molecular Transport/Janssen Biotech

Drug Profile

Research programme: inflammatory bowel diseases therapeutic- Applied Molecular Transport/Janssen Biotech

Latest Information Update: 02 Feb 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Applied Molecular Transport
  • Developer Applied Molecular Transport; Janssen Biotech
  • Class Proteins
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Research Inflammatory bowel diseases

Most Recent Events

  • 28 Jan 2015 Drug candidate to be used for the treatment of inflmmatory bowel disease licensed to Janssen Biotech worldwide
  • 28 Jan 2015 Early research in Inflammatory bowel disease in USA (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top